P. Sliwinski (Warsaw, Poland), P. L. Enright (Tucson, United States of America)
Diabetes as a risk factor for diaphragmatic paralysis in heart surgery
M. A. Merino, G. Juan, E. Rubio, M. Ramón, A. Montero (Alzira, Valencia, Spain)
|  |
Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus
C. Babayigit, A. Senyigit, A. Tuzcu (Hatay, Diyarbakir, Turkey)
| |
Endothoracic goitre: radiological and functional changes after one year follow-up
N. Bengoa, M. Albareda, C. Santiveri, J. Viguera, E. Delgado, R. Calvet, A. Mestron, J. L. Marin, L. Vila (Barcelona, Spain)
| |
Differences in pulmonary function tests (PFTs) in patients with pulmonary lymphangioleiomyomatosis (LAM) and multiple benign pulmonary leiomyomatosis (MPL)
M. Y. Kameneva, L. N. Novikova, O. P. Baranova (St Petersburg, Russia)
| |
Applicability of Caucasian prediction equations for spirometry interpretation in north Indian patients
A. N. Aggarwal, D. Gupta, D. Behera, S. K. Jindal (Chandigarh, India)
| |
Lung function in patients with chronic renal failure (CRF)
H. Dmenska, P. S. Gutkowski (Warsaw, Poland)
| |
Smoking cessation effects in diffusing capacity for carbon monoxide in healthy smokers
S. Andre, F. Oliveira, R. Ferreira, M. Raposo, H. Lucas, M. C. Abreu (Lisbon, Portugal)
| |
Analysis of spirometric responsiveness to beta2 agonist in the diagnosis of asthma
T. Kamimura, Y. Oshita, T. Koga, H. Aizawa (Kurume, Japan)
| |
Possible failure of bodyplethysmography and impulse oscillometry in children with obstruction – pilot study
J. Radlinski, W. Tomalak, A. Pogorzelski (Rabka, Poland)
| |
Analysis of bronchodilator response in patients with controlled asthma
T. Koga, T. Kamimura, Y. Oshita, H. Koga, H. Aizawa (Kurume, Japan)
| |
Pulmonary function in the rehabilitation period of severe acute respiratory syndrome (SARS)
J. Zheng (Guangzhou, China)
| |
Chronic cough, vocal cord dysfunction and nutrition
C. B. Bucca, P. Bigo, E. Panaro, L. Brussino, A. Roccati, G. Rolla (Turin, Italy)
| |
The fourier transform (FT) of the forced expiratory flow (FEF) curve provides a sensitive screening index for chronic lung disease
A. Anogeianaki, G. Ilonidis, G. Anogianakis, N. N. Negrev, A. Klisarova, N. Soumelidis, C. Pitsalidis (Thessaloniki, Greece; Varna, Bulgaria)
| |
Bronchial hiperresponsiveness to methacholine in wood smoke COPD
M. Gonzalez-Garcia, C. Torres-Duque, A. Bustos, D. Maldonado (Bogota, Colombia)
| |
Exhaled nitric oxide after bronchoscopy
R. Krenke, T. Przybylowski, K. Hildebrand, A. Fangrat, K. Górska, R. Chazan (Warsaw, Poland)
| |
Measuring cough(C): C-PEF; C-PVT new signs for an old symptom
F. Dalmasso, E. Isnardi, L. Sudaro, R. Mantovano, A. Mazzuccato (Turin, Italy)
| |
Latent alveolar abnormalities in inflammatory bowel disease
M. R. Charfi, N. Fajraoui, M. H. Dougui, M. Zbiba, S. Boubaker (La Marsa, Tunisia)
| |
Detection of expiratory flow limitation during spontaneous breathing in patients with sarcoidosis
A. Chronaiou, M. Mihailidou, M. Kontogiorgi, P. Latsi, E. Kosmas, A. Rapti, A. Koutsoukou, D. Orphanidou, N. G. Koulouris (Athens, Greece)
| |
Monitoring airway status by flow-standardized breath sound intensity
J. Gnitecki, S. Maiti, M. Barzanji, H. Pasterkamp (Winnipeg, Canada)
| |
Auscultatory forced expiratory time as a predictor of FEV1 and as a clinical test of airway obstruction
N. D. Cantillas, T. C. Atienza, C. S. Dalisay (Dilliman Quezon City, The Philippines)
| |